Results from a multiple morbidities testing program offering rapid HIV testing bundled with hepatitis and sexually transmitted infection testing

Public Health Reports

Volumn 123, Issue SUPPL. 3, 2008, Pages 63-69

  Reynolds, Grace L ^a   Fisher, Dennis G ^a   Napper, Lucy E ^a   Marsh, Kimberly A ^a   Willey, Christine ^a   Brooks, Ryan ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHLAMYDIASIS; CLINICAL FEATURE; COMMUNITY; CONTROLLED STUDY; DRUG USE; FEMALE; GONORRHEA; HEALTH PROGRAM; HEPATITIS A; HEPATITIS B; HEPATITIS C; HIGH RISK BEHAVIOR; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LESBIAN; MALE; MALE HOMOSEXUAL; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTITUTION; SYPHILIS; UNITED STATES; BAYES THEOREM; DISEASE TRANSMISSION; HEALTH CARE QUALITY; HEPATITIS; MASS SCREENING; PATHOPHYSIOLOGY; PILOT STUDY; QUESTIONNAIRE; SEXUALLY TRANSMITTED DISEASE; STATISTICAL MODEL;

BAYES THEOREM; FEMALE; HEPATITIS; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; PILOT PROJECTS; PROGRAM EVALUATION; QUESTIONNAIRES; SEXUALLY TRANSMITTED DISEASES;

EID: 60549113001     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/00333549081230s308     Document Type: Article

References (23)

1. Ziek K, Goldstein MF, Beardsley M, Deren S, Tortu S. Factors associated with HIV testing and returning for test results in a sample of out-of-treatment drug users. J Drug Issues 2000;30:675-686
2. Molitor F, Bell RA, Truax SR, Ruiz JD, Sun RK. Predictors of failure to return for HIV test results and counseling by test site type. AIDS Educ Prev 1999;11:1-13.
3. Sullivan PS, Lansky A, Drake A; HITS-2000 Investigators. Failure to return for HIV test results among persons at high risk for HIV infection: results from a multistate interview project. J Acquir Immune Defic Syndr 2004;35:511-518
4. Kassler WJ, Dillon BA, Haley C, Jones WK, Goldman A. On-site rapid HIV testing with same-day results and counseling. AIDS 1997;11:1045-1051
5. Liang TS, Erbelding E, Jacob CA, Wicker H, Christmyer C, Brunson S, et al. Rapid HIV testing of clients of a mobile STD/HIV clinic. AIDS Patient Care STDS 2005;19:253-257
6. Reynolds GL, Fisher DG, Henry CL, Perez MJ. Mobile post-HIV test counseling [letter re: Ellen JM, Liang TS, Jacob CA, Erbelding E, Christmyer C. Post-HIV test counseling of clients in a mobile STD/HIV clinic. Int J STD AIDS 2004;15:728-31]. Int J STD AIDS 2005;16:457.
7. Kelen GD, Shahan JB, Quinn TC. Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing. Ann Emerg Med 1999;33:147-155
8. Stopka TJ, Marshall C, Bluthenthal RN, Webb DS, Truax SR. HCV and HIV counseling and testing integration in California: an innovative approach to increase HIV counseling and testing rates. Public Health Rep 2007;122(Suppl 2):68-73.
9. Fisher DG, Reynolds GL, Jaffe A, Perez MJ. Hepatitis and human immunodeficiency virus co-infection among injection drug users in Los Angeles County, California. J Addict Dis 2006;25:25-32.
10. Dowling-Guyer S, Johnson ME, Fisher DG, Needle R, Watters J, Anderson M, et al. Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment 1994;1:383-392
11. Needle R, Fisher DG, Weatherby N, Chitwood D, Booth R, Watters J, et al. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav 1995;9:242-250
12. McConnaughy EA, DiClemente CC, Prochaska JO, Velicer WF. Stages of change in psychotherapy: a follow-up report. Psychotherapy 1989;26:494-503.
13. Carnes P. Contrary to love: helping the sexual addict. Minneapolis: CompCare Publishers; 1989.
14. Carnes P. Don't call it love: recovery from sexual addiction. New York: Bantam Books; 1991.
15. Amirkhan JH. Criterion validity of a coping measure. J Pers Assess 1994;62:242-261
16. Kalichman SC, Rompa D. Sexual sensation seeking and sexual compulsivity scales: reliability, validity, and predicting HIV risk behavior. J Pers Assess 1995;65:586-601.
17. Reynolds GL, Fisher DG, Jaffe A, Edwards J. Follow-up for medical care among drug users with hepatitis C. Eval Health Prof 2006;29:355-366
18. DiaSorin Inc. Enzyme immunoassay for the detection of total antibodies to hepatitis A virus (anti-HAV) in human serum or plasma. Package insert. Stillwater (MN): DiaSorin Inc.; 2005.
19. Diagnostic Products Corporation. Immulite 2000: anti-HBc total antibodies to hepatitis B core antigen. Package insert. Los Angeles: Diagnostic Products Corporation; 2006.
20. Abbott Laboratories. Hepatitis C virus encoded antigen (recombinant c100-3, HC-31, and HC-34) Abbott HCV EIA 2.0. Package insert. Abbott Park (IL): Abbott Laboratories Diagnostics Division; 2004.
21. Arlington Scientific, Inc. (ASI). ASI RPR card test for syphilis. Package insert. Springville (UT): ASI; 2006.
22. Fujirebio Diagnostics Inc. SERODIA®-TP·PA: reagents for the detection of antibodies to Treponema pallidum. Package insert. Malvern (PA): Fujirebio Diagnostics Inc.; 2006.
23. Gen-Probe Inc. Gen-Probe APTIMA combo 2 assay. Package insert. San Diego: Gen-Probe Inc.; 2007.